Panic disorder and substance use: Clinical significance and psychopathological dynamics;Disturbo di panico e uso di sostanze: Significato clinico e dinamiche psicopatologiche

Italian Journal of Psychopathology

Volumn 14, Issue 3, 2008, Pages 307-315

  Maremmani, Icro ^a,b,c   Pacini, M ^a,c   Romano, A ^a,c   Popovic, D ^a   Maremmani, A G I ^b   Deltito, J ^c,d   Perugi, G ^a,c  

^a UNIVERSITY OF PISA   (Italy)

^b AU CNS   (Italy)

^c G DE LISIO INSTITUTE OF BEHAVIOURAL SCIENCES   (Italy)

^d NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Addiction; Bipolar Disorder; Panic Disorder; Substance Abuse

Indexed keywords

ANXIOLYTIC AGENT;

ALCOHOLISM; ARTICLE; BIPOLAR DISORDER; COCAINE DEPENDENCE; COMORBIDITY; DISEASE ASSOCIATION; DRUG DEPENDENCE; EVIDENCE BASED MEDICINE; HUMAN; NEUROBIOLOGY; NEUROCHEMISTRY; OPIATE ADDICTION; PANIC; PHOBIA; PROGNOSIS; PSYCHODYNAMICS; SELF MEDICATION; SUBSTANCE ABUSE; TRANQUILIZING ACTIVITY;

EID: 56849124362     PISSN: 15921107     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Khantzian E J. Psychological (structural) vulnerabilities and the specific appeal of narcotics. Ann N Y Acad Sci 1982;398:24-32.
2. Perugi G, Frare F, Madaro D, Maremmani I, Akiskal HS. Alcohol abuse in social phobic patients: is there a bipolar connection? J Affect Disord 2002;68:33-9.
3. Maremmani I, Perugi G, Pacini M, Akiskal H. Toward a unitary perspective on the bipolar spectrum and substance abuse: opiate addiction as a paradigm. J Affect Disord 2006;93:1-12.
4. Maremmani I, Pacini M, Perugi G. Addictive disorders, bipolar spectrum and the impulsive link: the psychopathology of a self-regenerating pathway. Heroin Addict Relat Clin Probl 2005;7:33-46.
5. Sinha SS, Goetz RR, Klein DF. Physiological and behavioral effects of naloxone and lactate in normal volunteers with relevance to the pathophysiology of panic disorder. Psychiatry Res 2007;149:309-14.
6. Gorman JM, Kent JM, Sullivan GM, Coplan JD. Neuroanatomical hypothesis of panic disorder, revised. Am J Psychiatry 2000;157:493-505.
7. Cameron OG, Huang GC, Nichols T, Koeppe RA, Minoshima S, Rose D, et al. Reduced gamma-aminobutyric acid(a)-benzodiazepine binding sites in insular cortex of individuals with panic disorder. Arch Gen Psychiatry 2007;64:793-800.
8. Lewis RV, Stern AS. Biosynthesis of the enkephalins and enkephalin-containing polypeptides. Annu Rev Pharmacol Toxicol 1983;23:353-72.
9. Patton GC, Coffey C, Carlin JB, Degenhardt L, Lynskey M, Hall W. Cannabis use and mental health in young people: cohort study. Br Med J 2002;325:1195-8.
10. Cosci F, Schruers KR, Abrams K, Griez EJ. Alcohol use disorders and panic disorder: a review of the evidence of a direct relationship. J Clin Psychiatry 2007;68:874-80.
11. Schuckit MA, Hesselbrock V. Alcohol dependence and anxiety disorders: what is the relationship? Am J Psychiatry 1994;151:1723-34.
12. Chignon JM, Lepine JP. Panic disorder and alcoholism: effect of comorbidity. Can J Psychiatry 1993;38:485-93.
13. Reich J, Chaundrym D. Personality of panic disorder alcohol abusers. J Nerv Ment Dis 1987;175:224-8.
14. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, et al. Comorbidity of mental disorders with alchool and other drug abuse. JAMA 1990;19:2511-8.
15. Brugnoli R. Il panico e l'agorafobia. In: Pancheri P, a cura di. La doppia diagnosi: disturbi psichiatrici e dipendenza da sostanze. Firenze: Scientific Press s.r.I. 2002.
16. Schuckit MA, Tipp JE, Bucholz KK, Nurnberger JI, Hesselbrock Crowe, RR, Kramer J. The life-time rates of three major mood disorders and four major anxiety disorders in alcoholics and controls. Addiction 1997;92:1289-304.
17. George DT, Lindquist T, Ragan PW, Alim T, Eckardt MJ, Linnoila M. Effects of alcoholism on the incidence of lactate-induced panic attacks. Biol Psychiatry 1997;42:992-9.
18. Kushner MG, MacKenzie TB, Fiszdon J, Valentiner DP, Foa E, Anderson N, et al. The effects of alcohol consumption on laboratory-induced panic and state anxiety. Arch Gen Psychiatry 1996;53:264-70.
19. Cox BJ, Swinson RP, Shulman ID, Kuch K, Reichman JT. Gender effects and alcohol use in panic disorder with agoraphobia. Behav Res Therapy 1993;31:413-6.
20. Zvolensky MJ, Bernstein A, Sachs-Ericsson N, Schmidt NB, Buckner JD, Bonn-Miller MO. Lifetime associations between cannabis use, abuse and dependence and panic attacks in a representative sample. J Psychiatr Res 2006;40:477-86.
21. Thomas H. A community survey of adverse effects of cannabis use. Drug Alcohol Depend 1996;42:201-7.
22. Zuardi AW. Action of cannabidiol on the anxiety and the anxiety and other effects produced by delta-9-thc in normal subjects. Psychopharmacology 1982;76:245-50.
23. Fabre LF, McLendon D. The efficacy and safety of nabilone (a synthetic cannabinoid) in the treatment of anxiety. J Clin Pharmacol 1981;21:377-82.
24. Tournier M, Sorbara F, Gindre C, Swendsenm JD, Verdoux H. Cannabis use and anxiety in daily life: a naturalistic investigation in a non-clinical population. Psychiatry Res 2003;118:1-8.
25. Moran C. Depersonalization and agoraphobia associated with marijuana use. Br J Med Psychol 1986;59:187-96.
26. Naditch MP. Acute adverse reaction to psychoactive drugs, drug use and psychopathology. J Abnorm Psychol 1974:83;394-403.
27. Fabian WD, Fishkin SM. Psychological absorption: affect investment in marijuana intoxication. J Nerv Ment Dis 1991;179:39-43.
28. Dannon PN, Lowengrub K, Amiaz R, Grunhaus L, Kotler M. Comorbid cannabis use and panic disorder: short term and long term follow-up study. Hum Psychopharmacol 2004;19:97-101.
29. Ray R, Pal H, Kumar R, Maulick P, Mangla R. Post-marketing surveillance of buprenorphine. Pharmacoepidemiol Drug Saf 2004;13:615-9.
30. Senay EC, Adams EH, Geller A, Inciardi JA, Munoz A, Schnoll SH, et al. Physical dependence on ultram (tramadol hydrochloride) : both opioid-like and atypical withdrawal symptoms occur. Drug Alcohol Depend 2003;69:233-41.
31. Maremmani I, Marini G, Fornai F. Naltrexone induced panic attacks. Am J Psychiatry 1998;155:447.
32. Luby ED, Marrazzi MA, Kinzie J. Treatment of chronic anorexia nervosa with opiate blockade. J Clin Psychopharmacol 1987;7:52-3.
33. Kane FJJ, Pokorny A. Mental and emotional disturbance with pentazocine (talwin) use. South Med J 1975;68:808-11.
34. Liebowitz MR, Gorman JM, Fyer AJ, Dillon DJ, Klein DF. Effects of naloxone on patients with panic attacks. Am J Psychiatry 1984;141:995-7.
35. Ahmad B, Mufti KA, Farooq S. Psychiatric comorbidity in substance abuse (opioids). J Pak Med Assoc 2001;51:183-6.
36. Rosen MI, Kosten T. Cocaine associated panic attacks in methadone maintained patients. Am J Drug Alcohol Abuse 1992;18:57-62.
37. Sullivan MD, Edlund MJ, Steffick D, Unutzer J. Regular use of prescribed opioids: association with common psychiatric disorders. Pain 2005;119:95-103.
38. Gold MS, Pottash AC, Sweeney DR, Kleber HD, Redmond E. Rapid opiate detoxification: clinical evidence of antidepressant and antpanic effects of opiates. Am J Psychiatry 1979;136:982-3.
39. Gold MS, Pottash AL, Sweeney DR, Davies RK, Kleber HD. Clonidine decreases opiate withdrawal-related anxiety: possible opiate noradrenergic interaction in anxiety and panic. Subst Alcohol Actions Misuse 1980;1:239-46.
40. Gold MS, Pottash AC, Extein IL, Kleber HD. Neuro anatomical sites of action of clonidine in opiate withdrawal: the locus coeruleus connection. Prog Clin Biol Res 1981;71:285-98.
41. Stine SM, Southwick SM, Petrakis IL, Kosten TR, Charney DS, Krystal JH. Yohimbine-induced withdrawal and anxiety symptoms in opioid-dependent patients. Biol Psychiatry 2002;51:642-51.
42. Bango J, Fadon P, Mata F, Rubio G, Santo-Domingo J. Psychiatric disorders and consumption of ecstasy drug (MDMA): review of published case reports. Actas Luso Esp Neurol Psiquiatr Cienc Afines 1998;26:260-3.
43. Djenderedijan A, Tashjian R. Agoraphobia following amphetamine withdrawal. J Clin Psychiatry 1982;43:248-9.
44. Pennings EJ, Konijn KZ, de Wolff FA. Clinical and toxicologic aspects of the use of ecstasy. Ned Tijdschr Geneeskd 1998;142:1942-6.
45. Schifano F, Di Furia L, Forza G, Minicuci N, Bricolo R. MDMA (ecstasy) consumption in the context of polydrug abuse: a report on 150 patients. Drug Alcohol Depend 1998;52:85-90.
46. Liechti ME, Kunz I, Kupferschmidt H. Acute medical problems due to ecstasy use. Case-series of emergency department visits. Swiss Med Wkly 2005;135:652-7.
47. O'Brien MS, Wu LT, Anthony JC. Cocaine use and the occurrence of panic attacks in the community: a case-crossover approach. Subst Use Misuse 2005;40:285-97.
48. Anthony JC, Tien AY, Petronis KR. Epidemiologic evidence of cocaine use and panic attacks. Am J Epidemiol 1989;129:543-9.
49. Newcomb MD, Bentler PM, Fahy B. Cocaine use and psychopathology: associations among young adults. Int J Addict 1987;22:1167-88.
50. Jensen CF, Cowley DS, Walker RD. Drug preference of alcoholic polydrug abusers with and without panic. J Clin Psychiatry 1990;51:189-91.
51. McDougle C, Black J, Malison R, Zimmermann R, Kosten T, Heninger G, et al. Noradrenergic dysregulation during discontinuation of cocaine use in addicts. Arch Gen Psychiatry 1994;51:713-9.
52. Louie AK, Lannon RA, Ketter TA. Treatment of cocaine-induced panic disorder. Am J Psychiatry 1989;146:40-4.
53. Aronson TA, Craig TJ. Cocaine precipitation of panic disorder. Am J Psychiatry 1986;143:643-5.
54. Bystritsky A, Ackerman DL, Pasnau RO. Low dose desipramine treatment of cocaine-related panic attacks. J Nerv Ment Dis 1991;179:755-8.
55. Valentiner DP, Mounts NS, Deacon BJ. Panic attacks, depression and anxiety symptoms and substance use behaviors among late adolescence. J Anxiety Disord 2004;18:573-85.
56. Goldenberg IM, Mueller T, Fierman FJ, Gordon A, Pratt L, COx K, et al. Specificity of substance use in anxiety-disordered subjects. Compr Psychiatry 1995;36:319-28.
57. Busto UE, Romach MK, Sellers EM. Multiple drug use and psychiatric comorbidity in patients admitted to the hospital with severe benzodiazepine dependence. J Clin Psychopharmacol 1996;16:51-7.
58. Katerndal DA, Realini JP. Relationship between substance abuse and panic attacks. Addict Behav 1999;24:731-6.
59. Sareen J, Chartier M, Paulus MP, Stein MB. Illict drug use and anxiety disorders: findinds from two community surveys. Psychiatry Res 2006;142:11-7.
60. Deacon BJ, Valentiner DP. Substance use and non-clinical panic attacks in a young adult sample. J Subst Abuse 2000;11:7-15.
61. Perugi G, Akiskal HS. The soft bipolar spectrum redefined: focus on the cyclothymic anxious-sensitive, impulse discontrol, and binge-eating connection in bipolar II and related condition. Psychiatric Clin North Am 2002;25:713-37.
62. Masi G, Toni C, Perugi G, Mucci M, Millepiedi S, Akiskal HS. Anxiety disorders in children and adolescents with bipolar disorder: a neglected comorbidity. Can J Psychiatry 2001;46:797-802.